# Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

> **NCT05032053** · — · RECRUITING · sponsor: **Xijing Hospital** · enrollment: 3000 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Antithrombotic drugs

## Key facts

- **NCT ID:** NCT05032053
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-07-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05032053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05032053, "Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05032053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*